Naloxone, the opioid overdose-reversing medication commonly known by its brand name Narcan, was central to the response of ...

A major drug investigation in Crawford County resulted in the seizure of a large quantity of illegal drugs, including ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Florida’s importation program hasn’t brought in a single Canadian drug. It’s not cost-effective and it could be dangerous.

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

A growing disconnect remains between what generics are approved and what are actually accessible, GoodRx said.

Eli Lilly’s Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lilly ...

The US generic drug market size reached USD 93.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...

Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.